PARIS — Early implantation of an intra-aortic balloon pump (IABP) in patients with decompensated heart failure (HF) and low output provided more effective treatment than inotropic agents in a small ...

MUNICH, Germany—Although use of an intra-aortic balloon pump (IABP) in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock appears safe, the technique does not improve ...

Continuing the trajectory seen at 30 days and 1 year, the long-term data from the IABP-SHOCK II trial reported today show no survival benefit for intra-aortic balloon pump (IABP) use in acute MI ...

The applicability and validity of registry data remains open to debate. When studying a patient cohort that is notoriously difficult to enroll in randomized trials, registry data can certainly add ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A balloon pump inserted in the aorta is currently the most widely used support device in the treatment of cardiogenic shock and, since its introduction in 1968, has been used in several million people ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. An intra-aortic balloon pump (IABP) is the device most frequently used as a bridge to surgical repair in ...

No 30-Day Mortality Reduction With Intraaortic Balloon Pump In patients with cardiogenic shock complicating acute myocardial infarction, for whom early revascularization strategy is planned, ...

Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...

Please provide your email address to receive an email when new articles are posted on . Teleflex announced FDA clearance for an intra-aortic balloon pump for the treatment of patients with severe ...

The US Food and Drug Administration (FDA) said Tuesday that since notifying physicians of particular intra-aortic balloon pump (IABP) device failures last November, two more patients have died and one ...

WAYNE, Pa., April 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced FDA 510(k) clearance of the AC3 Range™ Intra-Aortic ...